Compare DLTR & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DLTR | BNTX |
|---|---|---|
| Founded | 1986 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.9B | 24.2B |
| IPO Year | 1996 | 2019 |
| Metric | DLTR | BNTX |
|---|---|---|
| Price | $93.83 | $99.16 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 18 | 13 |
| Target Price | $123.35 | ★ $133.46 |
| AVG Volume (30 Days) | ★ 3.2M | 798.0K |
| Earning Date | 06-03-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 144.33 | N/A |
| EPS | ★ 6.22 | N/A |
| Revenue | ★ $19,411,800,000.00 | N/A |
| Revenue This Year | $8.48 | N/A |
| Revenue Next Year | $5.90 | $3.37 |
| P/E Ratio | $15.20 | ★ N/A |
| Revenue Growth | ★ 10.43 | N/A |
| 52 Week Low | $83.11 | $79.81 |
| 52 Week High | $142.40 | $124.00 |
| Indicator | DLTR | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 33.59 | 49.81 |
| Support Level | $84.71 | $99.08 |
| Resistance Level | $105.99 | $113.05 |
| Average True Range (ATR) | 3.90 | 3.49 |
| MACD | -0.46 | -0.54 |
| Stochastic Oscillator | 1.96 | 22.79 |
Founded in 1986, Dollar Tree operates almost 9,000 small-box discount stores across the United States and Canada, offering roughly 85% of its merchandise under $2. The chain targets value-conscious suburban and urban shoppers with a mix of consumables (49% of sales), variety (45%), and seasonal goods (6%). In fiscal 2024, Dollar Tree generated over $17 billion in sales, through its multi-price strategy, higher-margin discretionary assortments, and private-label products that account for nearly one-third of sales.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.